Other than the upregulation of GLT-1 expression, the attenuation of neuroinflammation and of oxidative stress, as well as providing neuroprotection for various neurodegenerative diseases we find it useful in animal models of AD, PD and ALS [56,57,58]. This evidence concerns the gene SLC1A2 and neurodegenerative disease.